• 1
    Gao, G. F., Tormo, J., Gerth, U. C., Wyer, J. R., McMichael, A. J., Stuart, D. I., Bell, J. I. et al., Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2. Nature 1997. 387: 630634.
  • 2
    Gao, G. F., Rao, Z. and Bell, J. I., Molecular coordination of alphabeta T-cell receptors and coreceptors CD8 and CD4 in their recognition of peptide-MHC ligands. Trends Immunol. 2002. 23: 408413.
  • 3
    Konig, R., Interactions between MHC molecules and co-receptors of the TCR. Curr. Opin. Immunol. 2002. 14: 7583.
  • 4
    Zamoyska, R., CD4 and CD8: Modulators of T-cell receptor recognition of antigen and of immune responses? Curr. Opin. Immunol. 1998. 10: 8287.
  • 5
    Arcaro, A., Gregoire, C., Bakker, T. R., Baldi, L., Jordan, M., Goffin, L., Boucheron, N. et al., CD8beta endows CD8 with efficient coreceptor function by coupling T cell receptor/CD3 to raft-associated CD8/p56(lck) complexes. J. Exp. Med. 2001. 194: 14851495.
  • 6
    Purbhoo, M. A., Boulter, J. M., Price, D. A., Vuidepot, A. L., Hourigan, C. S., Dunbar, P. R., Olson, K. et al., The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor zeta chain. J. Biol. Chem. 2001. 276: 3278632792.
  • 7
    Veillette, A., Bookman, M. A., Horak, E. M. and Bolen, J. B., The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck. Cell 1988. 55: 301308.
  • 8
    Luescher, I. F., Vivier, E., Layer, A., Mahiou, J., Godeau, F., Malissen, B. and Romero, P., CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. Nature 1995. 373: 353356.
  • 9
    Wooldridge, L., van den Berg, H. A., Glick, M., Gostick, E., Laugel, B., Hutchinson, S. L., Milicic, A. et al., Interaction between the CD8 coreceptor and major histocompatibility complex class I stabilizes T cell receptor-antigen complexes at the cell surface. J. Biol. Chem. 2005. 280: 2749127501.
  • 10
    Wooldridge, L., Hutchinson, S. L., Choi, E. M., Lissina, A., Jones, E., Mirza, F., Dunbar, P. R. et al., Anti-CD8 antibodies can inhibit or enhance peptide-MHC class I (pMHCI) multimer binding: This is paralleled by their effects on CTL activation and occurs in the absence of an interaction between pMHCI and CD8 on the cell surface. J. Immunol. 2003. 171: 66506660.
  • 11
    Doucey, M. A., Goffin, L., Naeher, D., Michielin, O., Baumgartner, P., Guillaume, P., Palmer, E. and Luescher, I. F., CD3 delta establishes a functional link between the T cell receptor and CD8. J. Biol. Chem. 2003. 278: 32573264.
  • 12
    Guillaume, P., Legler, D. F., Boucheron, N., Doucey, M. A., Cerottini, J. C. and Luescher, I. F., Soluble major histocompatibility complex-peptide octamers with impaired CD8 binding selectively induce Fas-dependent apoptosis. J. Biol. Chem. 2003. 278: 45004509.
  • 13
    Potter, T. A., Rajan, T. V., Dick, R. F., 2nd and Bluestone, J. A., Substitution at residue 227 of H-2 class I molecules abrogates recognition by CD8-dependent, but not CD8-independent, cytotoxic T lymphocytes. Nature 1989. 337: 7375.
  • 14
    Xu, X. N., Purbhoo, M. A., Chen, N., Mongkolsapaya, J., Cox, J. H., Meier, U. C., Tafuro, S. et al., A novel approach to antigen-specific deletion of CTL with minimal cellular activation using alpha3 domain mutants of MHC class I/peptide complex. Immunity 2001. 14: 591602.
  • 15
    Schott, E. and Ploegh, H. L., Mouse MHC class I tetramers that are unable to bind to CD8 reveal the need for CD8 engagement in order to activate naive CD8 T cells. Eur. J. Immunol. 2002. 32: 34253434.
  • 16
    van der Merwe, P. A. and Davis, S. J., Molecular interactions mediating T cell antigen recognition. Annu. Rev. Immunol. 2003. 21: 659684.
  • 17
    Holler, P. D. and Kranz, D. M., Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. Immunity 2003. 18: 255264.
  • 18
    Hutchinson, S. L., Wooldridge, L., Tafuro, S., Laugel, B., Glick, M., Boulter, J. M., Jakobsen, B. K. et al., The CD8 T cell coreceptor exhibits disproportionate biological activity at extremely low binding affinities. J. Biol. Chem. 2003. 278: 2428524293.
  • 19
    Irwin, M. J., Heath, W. R. and Sherman, L. A., Species-restricted interactions between CD8 and the alpha 3 domain of class I influence the magnitude of the xenogeneic response. J. Exp. Med. 1989. 170: 10911101.
  • 20
    Price, D. A., Brenchley, J. M., Ruff, L. E., Betts, M. R., Hill, B. J., Roederer, M., Koup, R. A. et al., Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses. J. Exp. Med. 2005. 202: 13491361.
  • 21
    Gostick, E., Cole, D. K., Hutchinson, S. L., Wooldridge, L., Tafuro, S., Laugel, B., Lissina, A. et al., Functional and biophysical characterization of an HLA-A*6801-restricted HIV-specific T cell receptor. Eur. J. Immunol. 2007. 37: 479486.
  • 22
    Devine, L., Sun, J., Barr, M. R. and Kavathas, P. B., Orientation of the Ig domains of CD8 alpha beta relative to MHC class I. J. Immunol. 1999. 162: 846851.
  • 23
    Sun, J. and Kavathas, P. B., Comparison of the roles of CD8 alpha alpha and CD8 alpha beta in interaction with MHC class I. J. Immunol. 1997. 159: 60776082.
  • 24
    Leishman, A. J., Naidenko, O. V., Attinger, A., Koning, F., Lena, C. J., Xiong, Y., Chang, H. C. et al., T cell responses modulated through interaction between CD8alphaalpha and the nonclassical MHC class I molecule, TL. Science 2001. 294: 19361939.
  • 25
    Zippelius, A., Pittet, M. J., Batard, P., Rufer, N., de Smedt, M., Guillaume, P., Ellefsen, K. et al., Thymic selection generates a large T cell pool recognizing a self-peptide in humans. J. Exp. Med. 2002. 195: 485494.
  • 26
    Salio, M., Shepherd, D., Dunbar, P. R., Palmowski, M., Murphy, K., Wu, L. and Cerundolo, V., Mature dendritic cells prime functionally superior melan-A-specific CD8+ lymphocytes as compared with nonprofessional APC. J. Immunol. 2001. 167: 11881197.
  • 27
    Yee, C., Savage, P. A., Lee, P. P., Davis, M. M. and Greenberg, P. D., Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. J. Immunol. 1999. 162: 22272234.
  • 28
    Kuball, J., Schmitz, F. W., Voss, R. H., Ferreira, E. A., Engel, R., Guillaume, P., Strand, S. et al., Cooperation of human tumor-reactive CD4+ and CD8+ T cells after redirection of their specificity by a high-affinity p53A2.1-specific TCR. Immunity 2005. 22: 117129.
  • 29
    Kersh, E. N., Shaw, A. S. and Allen, P. M., Fidelity of T cell activation through multistep T cell receptor zeta phosphorylation. Science 1998. 281: 572575.
  • 30
    Davis, M. M., Boniface, J. J., Reich, Z., Lyons, D., Hampl, J., Arden, B. and Chien, Y., Ligand recognition by alpha beta T cell receptors. Annu. Rev. Immunol. 1998. 16: 523544.
  • 31
    Hampl, J., Chien, Y. H. and Davis, M. M., CD4 augments the response of a T cell to agonist but not to antagonist ligands. Immunity 1997. 7: 379385.
  • 32
    Madrenas, J., Chau, L. A., Smith, J., Bluestone, J. A. and Germain, R. N., The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands. J. Exp. Med. 1997. 185: 219229.
  • 33
    Sewell, A. K., Harcourt, G. C., Goulder, P. J., Price, D. A. and Phillips, R. E., Antagonism of cytotoxic T lymphocyte-mediated lysis by natural HIV-1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides. Eur. J. Immunol. 1997. 27: 23232329.
  • 34
    Kersh, G. J., Kersh, E. N., Fremont, D. H. and Allen, P. M., High- and low-potency ligands with similar affinities for the TCR: The importance of kinetics in TCR signaling. Immunity 1998. 9: 817826.
  • 35
    Lyons, D. S., Lieberman, S. A., Hampl, J., Boniface, J. J., Chien, Y., Berg, L. J. and Davis, M. M., A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity 1996. 5: 5361.
  • 36
    Zal, T., Zal, M. A. and Gascoigne, N. R., Inhibition of T cell receptor-coreceptor interactions by antagonist ligands visualized by live FRET imaging of the T-hybridoma immunological synapse. Immunity 2002. 16: 521534.
  • 37
    Altman, J. D., Moss, P. A., Goulder, P. J., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J. and Davis, M. M., Phenotypic analysis of antigen-specific T lymphocytes. Science 1996. 274: 9496.
  • 38
    Klenerman, P., Cerundolo, V. and Dunbar, P. R., Tracking T cells with tetramers: New tales from new tools. Nat. Rev. Immunol. 2002. 2: 263272.
  • 39
    Boniface, J. J., Rabinowitz, J. D., Wulfing, C., Hampl, J., Reich, Z., Altman, J. D., Kantor, R. M. et al., Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands. Immunity 1998. 9: 459466.
  • 40
    Purbhoo, M. A., Irvine, D. J., Huppa, J. B. and Davis, M. M., T cell killing does not require the formation of a stable mature immunological synapse. Nat. Immunol. 2004. 5: 524530.
  • 41
    Gao, G. F., Willcox, B. E., Wyer, J. R., Boulter, J. M., O'Callaghan, C. A., Maenaka, K., Stuart, D. I. et al., Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8alphaalpha. J. Biol. Chem. 2000. 275: 1523215238.
  • 42
    Dustin, M. L., Golan, D. E., Zhu, D. M., Miller, J. M., Meier, W., Davies, E. A. and van der Merwe, P. A., Low affinity interaction of human or rat T cell adhesion molecule CD2 with its ligand aligns adhering membranes to achieve high physiological affinity. J. Biol. Chem. 1997. 272: 3088930898.
  • 43
    Gakamsky, D. M., Luescher, I. F., Pramanik, A., Kopito, R. B., Lemonnier, F., Vogel, H., Rigler, R. and Pecht, I., CD8 kinetically promotes ligand binding to the T-cell antigen receptor. Biophys. J. 2005. 89: 21212133.
  • 44
    Price, D. A., Sewell, A. K., Dong, T., Tan, R., Goulder, P. J., Rowland-Jones, S. L. and Phillips, R. E., Antigen-specific release of beta-chemokines by anti-HIV-1 cytotoxic T lymphocytes. Curr. Biol. 1998. 8: 355358.
  • 45
    Purbhoo, M. A., Sewell, A. K., Klenerman, P., Goulder, P. J., Hilyard, K. L., Bell, J. I., Jakobsen, B. K. and Phillips, R. E., Copresentation of natural HIV-1 agonist and antagonist ligands fails to induce the T cell receptor signaling cascade. Proc. Natl. Acad. Sci. USA 1998. 95: 45274532.